99 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 2 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
CACNA1ACalcium voltage-gated channel subunit alpha1 ADisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enhanced
CACNA1BCalcium voltage-gated channel subunit alpha1 BDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
CACNA1CCalcium voltage-gated channel subunit alpha1 CDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1DCalcium voltage-gated channel subunit alpha1 DCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Nuclear membraneMixed
CACNA1ECalcium voltage-gated channel subunit alpha1 EPredicted membrane proteins
Voltage-gated ion channels
Plasma membrane
Actin filaments
Cytosol
Tissue enriched
CACNA1FCalcium voltage-gated channel subunit alpha1 FDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CACNA1GCalcium voltage-gated channel subunit alpha1 GDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1HCalcium voltage-gated channel subunit alpha1 HDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Vesicles
Tissue enhanced
CACNA1SCalcium voltage-gated channel subunit alpha1 SDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CATSPER4Cation channel sperm associated 4Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
CNGA2Cyclic nucleotide gated channel alpha 2Predicted membrane proteins
Voltage-gated ion channels
Not detected
CNGA3Cyclic nucleotide gated channel alpha 3Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CNGB3Cyclic nucleotide gated channel beta 3Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
HCN1Hyperpolarization activated cyclic nucleotide gated potassium channel 1Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
HCN3Hyperpolarization activated cyclic nucleotide gated potassium channel 3Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCNA1Potassium voltage-gated channel subfamily A member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium voltage-gated channel subfamily A member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Cytosol
Not detected
KCNA2Potassium voltage-gated channel subfamily A member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium voltage-gated channel subfamily A member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium voltage-gated channel subfamily A member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium voltage-gated channel subfamily A member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNA6Potassium voltage-gated channel subfamily A member 6FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNB1Potassium voltage-gated channel subfamily B member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB2Potassium voltage-gated channel subfamily B member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoli
Plasma membrane
Midbody
Tissue enhanced
KCNC1Potassium voltage-gated channel subfamily C member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Nucleus
Nuclear membrane
Vesicles
Cytosol
Tissue enriched
KCNC2Potassium voltage-gated channel subfamily C member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Plasma membrane
Cytosol
Tissue enriched
KCNC3Potassium voltage-gated channel subfamily C member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC4Potassium voltage-gated channel subfamily C member 4Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Nucleoli
Cytosol
Mixed
KCND1Potassium voltage-gated channel subfamily D member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
NucleusMixed
KCND2Potassium voltage-gated channel subfamily D member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel subfamily D member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNF1Potassium voltage-gated channel modifier subfamily F member 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatusTissue enriched
KCNG1Potassium voltage-gated channel modifier subfamily G member 1Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
VesiclesTissue enhanced
KCNG2Potassium voltage-gated channel modifier subfamily G member 2Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNG3Potassium voltage-gated channel modifier subfamily G member 3Predicted membrane proteins
Voltage-gated ion channels
Cytoplasmic bodiesTissue enhanced
KCNH1Potassium voltage-gated channel subfamily H member 1Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesTissue enriched
KCNH3Potassium voltage-gated channel subfamily H member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleus
Mitochondria
Group enriched
KCNH5Potassium voltage-gated channel subfamily H member 5Predicted membrane proteins
Voltage-gated ion channels
Microtubules
Mitotic spindle
Tissue enhanced
KCNH7Potassium voltage-gated channel subfamily H member 7Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNH8Potassium voltage-gated channel subfamily H member 8Predicted membrane proteins
Voltage-gated ion channels
Plasma membraneTissue enhanced
KCNJ1Potassium voltage-gated channel subfamily J member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ10Potassium voltage-gated channel subfamily J member 10Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ11Potassium voltage-gated channel subfamily J member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ12Potassium voltage-gated channel subfamily J member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Cytosol
Group enriched
KCNJ14Potassium voltage-gated channel subfamily J member 14Predicted membrane proteins
Voltage-gated ion channels
NucleoliMixed
KCNJ15Potassium voltage-gated channel subfamily J member 15Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Vesicles
Plasma membrane
Cytosol
Tissue enhanced
KCNJ16Potassium voltage-gated channel subfamily J member 16Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesGroup enriched
KCNJ2Potassium voltage-gated channel subfamily J member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ3Potassium voltage-gated channel subfamily J member 3Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ5Potassium voltage-gated channel subfamily J member 5Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
Page of 2 | next »